JPRN-UMIN000015222已完成2 期
Phase II clinical trial of combination therapy with medium-chain triglycerides and ghrelin in patients with chronic obstructive pulmonary disease - Therapy with medium-chain triglycerides and ghrelin for chronic obstructive pulmonary disease
ational Hospital Organization Toneyama National Hospital0 个研究点目标入组 10 人开始时间: 2014年10月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients with malignant tumors 2) Patients with active infection 3) Patients with severe heart disease 4) Patients with hepatic failure (serum levels of AST and ALT greater than twice the normal upper limits) 5) Patients with renal failure (serum creatinine concentration >= 2.0 mg/dL) 6) Patients with asthma or who tested positive on an airway reversibility test 7) Patients who are or could be pregnant 8) Patients who are undergoing diabetes mellitus therapy or whose HbA1C>7.0 9) Patients whose drug regimen was changed within one month before participation in this study 10) In addition to the above exclusion criteria, patients judged to be inadequate to participate in this study by their physician
研究者
相似试验
已完成
2 期
Phase 2 trial of first-line combination therapy of cisplatin, pemetrexed and nivolumab in participants with unresectable malignant pleural mesotheliomamalignant pleural mesotheliomaJPRN-UMIN000030892Okayama Rosai Hospital18
尚未招募
不适用
Phase I and II trial of combination therapy using nab-Paclitaxel+Pertuzumab+Trastuzumab for HER2 positive metastatic breast cancermetastatic breast cancerJPRN-UMIN000035869The University of Tokushima Graduate School, Depertment of Thoracic, Endocrine surgery and Oncology, Institute of Health Bioscience30
进行中（未招募）
不适用
Phase II randomized trial of combination therapy of paclitaxel and bevacizumab versus paclitaxel, capecitabine and bevacizumab as first-line treatment for locally recurrent or metastatic breast cancer patients with HER2/neu negative tumor (ATX-study) - ATXEUCTR2006-006058-83-NLVU Medisch Centrum
招募中
2 期
A randomised phase II trial of combined therapy with CPT-11/CDDP versus CPT-11 alone in second-line treatment of advaneced or recurrent gastric cancer resistant to Docetaxel/Cisplatin/TS-1 (DCS) therapyGastric CancerJPRN-UMIN000003141Sapporo Medical University School of Medicine Dept. of Internal Medicine(4)80
进行中（未招募）
2 期
A phase II study for HER2 amplified advanced solid tumors (JUPITER trial)Solid tumorsHER2, solid tumorD009369JPRN-jRCT2031180150Ikeda Sadakatsu38